- BRP Home
- Priority Areas
- Funding Opportunities
- Data and Tools
- About BRP
I am a Psychiatric Clinical Translational Scientist.
I am a BBPSB Grantee.
University of California - Los Angeles
Michael Irwin, M.D., is one of the world's foremost experts on the psychoneuroimmunological pathways by which psychosocial and behavioral factors influence health and disease. He holds the Norman Cousins Distinguished Professorship in Department of Psychiatry and Biobehavioral Science at the UCLA Geffen School of Medicine and is Director of the Cousins Center for Psychoneuroimmunology at the UCLA Semel Institute and Director of the Mindful Awareness Research Center at the UCLA Semel Institute. His research is focused on understanding the reciprocal interactions between the immune and central nervous systems and the role of sleep disturbance on the molecular and cellular inflammatory signaling pathways that influence depression and physical health risk with a focus on cancer survivors and older adults.
Dr. Irwin discovered that stress activation of central neuropeptides (i.e., CRH) regulates cellular and innate immune responses, characterized a "conserved transcriptional response to adversity" in which stress both steers a reduction in anti-viral immunity and simultaneously induces transcriptional activation of inflammatory signaling, and demonstrated that sleep disturbance activates inflammatory signaling and accelerates biological aging, which increases risk for chronic disease and depression. Dr. Irwin was among the first to show that inflammation casually induces depression by regulating affect mechanisms, reward processing, and related neural sensitivities, which together guided his development of a novel social signal transduction theory of depression. His pioneering work in psychoneuroimmunology has defined the biological basis for the efficacy of behavioral and mind-body treatments to complement traditional biomedical approaches, augment anti-viral vaccine responses, and reverse inflammatory signaling and molecular markers of aging. Finally, Dr. Irwin has developed and empirically validated a curriculum-based mindfulness program for depression and insomnia, which is now instantiated in multi-site trials and disseminated globally by virtue of community outreach, an international training program, and web-based platforms.
Dr. Irwin's research has been supported continuously for over 25 years by his PI leadership of 30 R01 type awards from the NIH. Dr. Irwin is recipient of the Cousins Award for career achievement from the Psychoneuroimmunology Research Society; Excellence in Integrative Medicine Research Award from the European Society of Integrative Medicine; and Outstanding Faculty Research Mentor from UCLA. He has served as President for the Academy of Behavioral Medicine Research, the American Psychosomatic Society, and the Psychoneuroimmunology Research Society. He was a member of the Advisory Council of the National Center for Complementary and Alternative Medicine and Chairperson of NIH Center for Scientific Review, Mechanisms of Emotion, Stress and Health Study Section.
|Results 1 - 2 of 2.|
|Sleep Disturbance, Inflammation, and Cellular Aging in Breast Cancer Survivors
|Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms
To request edits to this profile, please contact Mary O’Connell at email@example.com.